Subscribe To
Cytodyn has multiple shots on goal with its flagship drug vyrologix to treat hiv, various cancers and even coronavirus
CytoDyn's main product candidate is Vyrologix, an injectable antibody that shows promise as an anti...
October 10, 2021, 6:29 am
Why vaxart shares are trading higher today
Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the compan...
October 8, 2021, 9:57 am
Why vaxart shares are trading higher today
Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the compan...
October 8, 2021, 9:57 am
Why vaxart shares are trading higher today
Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the compan...
October 8, 2021, 9:57 am
Why vaxart shares are surging in thursday's after-hours session
Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRx...
October 7, 2021, 4:57 pm
Why vaxart shares are surging in thursday's after-hours session
Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRx...
October 7, 2021, 4:57 pm
Why vaxart shares are surging in thursday's after-hours session
Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRx...
October 7, 2021, 4:57 pm
Unity biotechnology stock falls after updated data from wet amd candidate
Unity Biotechnology Inc (NASDAQ: UBX) announced 12-week data from its ongoing Phase 1 safety study of UBX1325 in diabetic macular edema (DME) and w...
October 5, 2021, 3:52 pm
Unity biotechnology stock falls after updated data from wet amd candidate
Unity Biotechnology Inc (NASDAQ: UBX) announced 12-week data from its ongoing Phase 1 safety study of UBX1325 in diabetic macular edema (DME) and w...
October 5, 2021, 3:52 pm
Unity biotechnology stock falls after updated data from wet amd candidate
Unity Biotechnology Inc (NASDAQ: UBX) announced 12-week data from its ongoing Phase 1 safety study of UBX1325 in diabetic macular edema (DME) and w...
October 5, 2021, 3:52 pm
Unity biotechnology stock falls after updated data from wet amd candidate
Unity Biotechnology Inc (NASDAQ: UBX) announced 12-week data from its ongoing Phase 1 safety study of UBX1325 in diabetic macular edema (DME) and w...
October 5, 2021, 3:52 pm
Unity biotechnology stock falls after updated data from wet amd candidate
Unity Biotechnology Inc (NASDAQ: UBX) announced 12-week data from its ongoing Phase 1 safety study of UBX1325 in diabetic macular edema (DME) and w...
October 5, 2021, 3:52 pm